Lyophilisate containing Ndiaminomethylene2-methyl-4,5-di-(methylsulfonyl)-benza mide

Details for Australian Patent Application No. 2005287591 (hide)

Owner Merck Patent GmbH

Inventors Schiroky, Dirk; Heckmann, Rita; Mahler, Hanns-Christian; Kress, Dorothee

Agent Davies Collison Cave

Pub. Number AU-A-2005287591

PCT Pub. Number WO2006/032386

Priority 10 2004 045 825.1 22.09.04 DE

Filing date 10 September 2005

Wipo publication date 30 March 2006

International Classifications

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07C 317/44 (2006.01) Sulfones

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/032386 Priority application(s): WO2006/032386

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287603-Floor panel and floor covering composed of such floor panels

2005287590-Cap for drug delivery devices